Press release
Gout Therapeutics Market Size Is Projected To Be Around $8 Billion By 2025:
Crystal Market Research
Gout is the most common form of inflammatory arthritis worldwide. It is characterized by pain, redness and tenderness in joints. Gout is crystal-deposition disease due to over production of uric acid above saturation level leading to crystal formation. The incidence of gout has been increasing rapidly worldwide with every six individuals in 1,000 suffering from gout and its related complications based on study conducted by US National Health and Nutrition Examination Surveys (NHANES). Gout conditions are more prevalent in men between ages of 40 to 50 whereas in women chances of developing gout infections increases after onset of menopause. Hence, rising incidence of gout will demand more advanced drugs for treating gout and its related conditions. Gout therapeutic market is expected to witness significant growth due to rise in elderly population, rise in obesity and approval of effective gout therapies.
Browse full research report with TOC on “Gout Therapeutics Market by Product Type and Disease Condition - Global Industry Analysis and Forecast to 2025” at: http://www.crystalmarketresearch.com/report/gout-therapeutics-market
Non-steroidal anti-inflammatory drugs (NSAIDs) segment dominated the global market in 2016. This can be attributed to number of factors such as low cost of NSAIDs, easy availability, and ability to induce anti-inflammatory response faster than other available drugs for gout attacks. Additionally, introduction of advanced and new drugs (such as TMX 67, Krystexxa, and Zurampic) for gout treatment, increase in adoption rate of gout drugs, and huge investments for drug designing and development are set to further drive the demand for NSAIDS. Corticosteroids segment is expected to witness slow growth due to reoccurrence of gout attack after withdrawal of steroids/drugs. Urate lowering drugs segment has seen tremendous growth in last few years due to their ability of producing strong anti-inflammatory response by inhibiting xanthine oxidase.
In 2016, the global market was dominated by North America. This large share can be attributed to number of factors such as rise in incidence of gout infections and high adoption of technologically advanced products. European market is expected to grow at considerable CAGR during the forecast period, due to increased number of drug approvals. For instance, in February 2016, AstraZeneca’s product, Zurampic in combination of xanthine oxidase inhibitor, was approved by European Union. Therefore, introduction of urate-lowering agents in European market will drive the market growth.
Request a sample copy of Gout Therapeutics Market Research Report @ http://www.crystalmarketresearch.com/report-sample/HC055
Some of the major companies are Merck& Co. Inc.; GlaxoSmithKline plc; Teijin Pharma Ltd.; Regeneron Pharmaceuticals; Novartis AG; Savient Pharmaceuticals; Takeda Pharmaceutical Company Ltd.; and AstraZeneca plc. Market is expected to grow further by national and international collaborations and partnership for developing safety profile in treating such conditions. For instance, in Dec 2015, Horizon Pharma plc acquires Crealta Holdings LLC for developing and commercialization of medicines such as KRYSTEXXA for treating refractory gout disease.
Key Findings of the Research Study:
• NSAIDs segment dominated the global market with almost two-fourth share in 2016, due to low cost and ability to produce strong anti-inflammatory response.
• Colchicine segment accounted for significant market share in 2016, due their ability to inhibit inflammatory action of Neutrophils.
• Chronic gout dominated the global market in 2016 owing to high prevalence of chronic gout infections worldwide.
• U.S. dominated the global market in 2016, due to high adoption of advanced drugs and treatment methods.
• Asia-Pacific is poised to grow at a high CAGR during the forecast period, owing to increase in population base suffering from gout infections and rise in adoption rate of gout therapies.
Inquire more about this report at:
http://www.crystalmarketresearch.com/send-an-enquiry/HC055
Gout therapeutic market is segmented as follows –
By Product Type:
• Colchicines
• Corticosteroids
• NSAIDs
•Urate-lowering Agents
By Disease Condition:
• Acute Gout
•Chronic Gout
By Region:
• North America
U.S
Canada
Mexico
• Europe
Germany
France
UK
Italy
Spain
Rest of Europe
• Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
• Rest of the World
Brazil
South Africa
Saudi Arabia
Turkey
United Arab Emirates
Others
Get Customization in the Report At:
http://www.crystalmarketresearch.com/customization/HC055
Related Reports:
Anti-Inflammatory Therapeutics Market by Indication and Drug Class - Global Industry Analysis and Forecast to 2025: http://www.crystalmarketresearch.com/report/anti-inflammatory-therapeutics-market
Global Respiratory Care Devices Market by Disorder and End User - Global Industry Analysis and Forecast to 2025: http://www.crystalmarketresearch.com/report/global-respiratory-care-devices-market
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Akhil V.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Blog: https://blog.crystalmarketresearch.com
Website: http://www.crystalmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gout Therapeutics Market Size Is Projected To Be Around $8 Billion By 2025: here
News-ID: 609441 • Views: …
More Releases from Crystal Market Research
Forklift Market By Power Source | Qualitative Insights, Key Enhancement | Global …
Crystal Market Research Present Advance research on - Forklift Market, approximates that the Forklift Industry size is anticipated to flourish at a significant CAGR in the future.
The Forklift Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Forklift is a little mechanical vehicle, having a power worked forked stage appended at the front to lift and move material over a…
Global Security Analytics Market Developing Research Methodology Analysis by 201 …
This report provides strategic study of the Global Security Analytics Market, and the growth forecast for the period 2014 to 2023. The scope of the report includes competitive analysis of various market segments based on key trends, competitive landscape analysis and key regional development status.
Kindly request for Sample Copy of Report @
https://www.crystalmarketresearch.com/report-sample/IC04706
This study provides insights about the Security Analytics Market in regards to its uses, benefits and in-depth look at…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
